Skip to content
CancerIndex

Publication

A Phase II Trial Using Grape Seed Extract for Prostate Cancer Patients With Nonmetastatic Prostate-Specific Antigen Progression After Local Therapy.

Paul Maroni, Tad A Manalo, Hannah Baker, Elizabeth R Kessler, Andrew Nicklawsky, Victor Trevisanut, Thomas W Flaig, Elaine T Lam, James C Moore, Dexiang Gao, Komal Raina, Rajesh Agarwal

Molecular carcinogenesisSep 27, 2026PMID 42801665doi:10.1002/mc.70183 Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Sep 29, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260929-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Prostate cancer (PCa) is a major cause of cancer-related death among American men. While androgen deprivation therapy (ADT) is commonly used in the treatment of rising prostate-specific antigen (PSA) levels after primary therapy, its adverse systemic side effects support exploring low-impact…

Read on PubMed

Linked entities

Linked entities (2)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Validated 1

Candidate 1

Registered trialsNCT03087903

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.